A PROMISE FOR A HEALTHIER TOMORROW

Napoperidone2 mgTablets

Napoperidone
Napoperidone
A second generation "atypical" antipsychotic; approved by the FDA for the treatment of schizophrenia.
Composition:

Each tablet contains: Iloperidone 2 mg.

A second generation atypical antipsychotic whose primary mechanism of action is within the subclass of combined D2/5-HT2A antagonism.

Propertise:
  • Napoperidone: shows differential efficacy with some patients who show otherantipsychotic therapy failure.
  • Napoperidone: possesses acute efficacy equivalent to other first line antipsychoticswith relapse prevention comparable to haloperidol.
  • Napoperidone: has an overall favourable tolerability profile, so may reduce overallside effects burden associated with long term antipsychotic therapy.
  • Napoperidone: is not associated with elevations in triglycerides or cholesterol.
Dosage & Administration:
  • Indicated for the treatment of adults with schizophrenia: the recommended starting dose of 1 mg twice daily.
  • Efficacy was demonstrated with Napoperidone in a dose range of 6-12 mg twicedaily (the max. recommended dose is 24 mg / day).
  • Napoperidone: can be administered without regard to meals.